Refresh

Norris Medicines Ltd. - Research Center

524414 NORRIS Group (XT) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

8.36 9.44 12.25 7.84 16.27
Expenses

Material consumed

3.40 5.61 8.83 4.59 10.29

Manufacturing expenses

1.23 - 1.26 1.62 2.03

Personnel expenses

2.30 2.33 3.10 3.23 3.81

Selling expenses

- - - 0.01 0.01

Adminstrative expenses

0.50 1.57 0.81 0.55 0.74

Expenses capitalised

- - - - -

Cost of sales

7.44 9.51 14.00 10.00 16.88

Operating profit

0.92 -0.07 -1.74 -2.16 -0.61

Other recurring income

0.01 0.03 0.05 0.09 0.04

Adjusted PBDIT

0.94 -0.05 -1.69 -2.07 -0.57

Financial expenses

1.50 1.48 1.63 0.88 0.73

Depreciation

0.63 0.66 0.67 0.73 0.71

Other write offs

- - - - -

Adjusted PBT

-1.19 -2.18 -3.99 -3.68 -2.01

Tax charges

0.56 1.08 0.97 -0.84 -0.33

Adjusted PAT

-1.75 -3.26 -4.96 -2.84 -1.68

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

-1.75 -3.26 -4.96 -2.84 -1.68

Earnigs before appropriation

-24.20 -22.45 -19.19 -14.23 -11.39

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-24.20 -22.45 -19.19 -14.23 -11.39
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com